GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Apresoline®
hydralazine is an approved drug (FDA (1953))
Compound class:
Synthetic organic
Comment: Hydralazine is a hydrazinophthalazine class anti-hypertensiove drug.
Hydralazine is on the World Health Organisation's List of Essential Medicines. Click here to access the pdf version of the WHO's 21st Essential Medicines list (2019). |
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. US FDA (1953) |
| WHO Essential Medicine | WHO Essential Medicines List (EML) (23rd List, 2023). Access PDF version. Click to view more information about the WHO Model Lists of Essential Medicines. |
IUPAC Name ![]() |
| 1-hydrazinylidene-1,2-dihydrophthalazine |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 1 | hydralazine |
Synonyms ![]() |
| Apresoline® |
Database Links ![]() |
|
| CAS Registry No. | 86-54-4 |
| ChEMBL Ligand | CHEMBL276832 |
| DrugBank Ligand | DB01275 |
| DrugCentral Ligand | 1384 |
| GtoPdb PubChem SID | 178103898 |
| PubChem CID | 3637 |
| RCSB PDB Ligand | HLZ |
| Search Google for chemical match using the InChIKey | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
| Search Google for chemicals with the same backbone | RPTUSVTUFVMDQK |
| Search PubMed clinical trials | hydralazine |
| Search PubMed titles | hydralazine |
| Search PubMed titles/abstracts | hydralazine |
| UniChem Compound Search for chemical match using the InChIKey | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | RPTUSVTUFVMDQK-UHFFFAOYSA-N |
| Wikipedia | Hydralazine |